Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSPSANTOS, Matheus P.CAUDURO, Leonardo F. R.FERREIRA, Marilia MarcondesMARTUCCI, Luiz FelipeVECCHIATTO, BrunoVILAS-BOAS, Eloisa AparecidaAMERICO, Anna Laura V.PEREIRA, Renata O.ROGERO, Marcelo MacedoFIORINO, PatriciaEVANGELISTA, Fabiana S.AZEVEDO-MARTINS, Anna Karenina2024-02-152024-02-152023FRONTIERS IN BIOSCIENCE-LANDMARK, v.28, n.11, article ID 312, 14p, 20232768-6701https://observatorio.fm.usp.br/handle/OPI/58058Background: Obesity is a worldwide concern due to its global rapid expansion and remarkable impact on individual's health by predisposing to several other diseases. About twice as many women as men suffer from severe obesity and, in fact, there are stages in a woman's life when weight gain and adiposity can result in greater damage to health. For example, obesity triples the chance of a woman developing gestational diabetes. Many hormones promote the metabolic adaptations of pregnancy, including progesterone, whose role in female obesity is still not well known despite being involved in many physiological and pathological processes. Methods: Here we investigated whether progesterone treatment at low dose can worsen the glucose metabolism and the morpho functional aspects of adipose tissue and pancreas in obese females. Mice were assigned into four groups: normocaloric diet control (NO-CO), high-fat and -fructose diet control (HFF-CO), normocaloric diet plus progesterone (NO-PG) and high-fat and -fructose diet plus progesterone (HFF-PG) for 10 weeks. Infusion of progesterone (0.25 mg/kg/day) was done by osmotic minipump in the last 21 days of protocol. Results: Animals fed a hypercaloric diet exhibited obesity with increased body weight (p < 0.0001), adipocyte hypertrophy (p < 0.0001), hyperglycemia (p = 0.03), and glucose intolerance (p = 0.001). HFF-CO and HFF-PG groups showed lower adiponectin concentration (p < 0.0001) and glucose-stimulated insulin secretion (p = 0.03), without differences in islet size. Progesterone attenuated glucose intolerance in the HFFPG group (p = 0.03), however, did not change morphology or endocrine function of adipose tissue and pancreatic islets. Conclusions: Taken together, our results showed that low dose of progesterone does not worsen the effects of hypercaloric diet in glycemic metabolism, morphology and function of adipose tissue and pancreatic islets in female animals. These results may improve the understanding of the mechanisms underlying the pathogenesis of obesity in women and eventually open new avenues for therapeutic strategies and better comprehension of the interactions between progesterone effects and obesity.engopenAccessobesityhypercaloric dietfemalesprogesteroneadipose tissuepancreatic isletsacylation-stimulating proteininsulin-resistancelangerhansestradiolpregnancycomplicationsmechanismsinsightsnumberratsarticleCopyright IMR PRESS10.31083/j.fbl2811312Biochemistry & Molecular BiologyCell Biology2768-6698